25 XP   0   0   10

Jiangsu Hengrui Medicine Co Ltd
Buy, Hold or Sell?

Let's analyse Jiangsu Hengrui Medicine Co Ltd together

PenkeI guess you are interested in Jiangsu Hengrui Medicine Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Jiangsu Hengrui Medicine Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Jiangsu Hengrui Medicine Co Ltd

I send you an email if I find something interesting about Jiangsu Hengrui Medicine Co Ltd.

Quick analysis of Jiangsu Hengrui Medicine Co Ltd (30 sec.)










What can you expect buying and holding a share of Jiangsu Hengrui Medicine Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.09
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥6.02
Expected worth in 1 year
¥7.86
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
¥2.48
Return On Investment
5.6%

For what price can you sell your share?

Current Price per Share
¥44.30
Expected price per share
¥35.51 - ¥48.53
How sure are you?
50%

1. Valuation of Jiangsu Hengrui Medicine Co Ltd (5 min.)




Live pricePrice per Share (EOD)

¥44.30

Intrinsic Value Per Share

¥-5.89 - ¥1.87

Total Value Per Share

¥0.13 - ¥7.89

2. Growth of Jiangsu Hengrui Medicine Co Ltd (5 min.)




Is Jiangsu Hengrui Medicine Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$5.3b$4.9b$392.1m7.4%

How much money is Jiangsu Hengrui Medicine Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$539m$625.1m-$86.1m-16.0%
Net Profit Margin18.4%17.5%--

How much money comes from the company's main activities?

3. Financial Health of Jiangsu Hengrui Medicine Co Ltd (5 min.)




What can you expect buying and holding a share of Jiangsu Hengrui Medicine Co Ltd? (5 min.)

Welcome investor! Jiangsu Hengrui Medicine Co Ltd's management wants to use your money to grow the business. In return you get a share of Jiangsu Hengrui Medicine Co Ltd.

What can you expect buying and holding a share of Jiangsu Hengrui Medicine Co Ltd?

First you should know what it really means to hold a share of Jiangsu Hengrui Medicine Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Jiangsu Hengrui Medicine Co Ltd is ¥44.30. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Jiangsu Hengrui Medicine Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Jiangsu Hengrui Medicine Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥6.02. Based on the TTM, the Book Value Change Per Share is ¥0.46 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.75 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.16 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Jiangsu Hengrui Medicine Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.080.2%0.080.2%0.100.2%0.100.2%0.080.2%
Usd Book Value Change Per Share0.060.1%0.060.1%0.100.2%0.100.2%0.070.2%
Usd Dividend Per Share0.020.0%0.020.0%0.020.1%0.020.0%0.010.0%
Usd Total Gains Per Share0.090.2%0.090.2%0.130.3%0.120.3%0.080.2%
Usd Price Per Share5.32-5.32-7.00-9.41-8.00-
Price to Earnings Ratio62.92-62.92-71.60-86.95-118.14-
Price-to-Total Gains Ratio62.20-62.20-55.34-79.21-109.50-
Price to Book Ratio6.40-6.40-9.12-15.61-22.37-
Price-to-Total Gains Ratio62.20-62.20-55.34-79.21-109.50-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share6.1134
Number of shares163
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.020.02
Usd Book Value Change Per Share0.060.10
Usd Total Gains Per Share0.090.12
Gains per Quarter (163 shares)13.9318.86
Gains per Year (163 shares)55.7475.44
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1144146126365
2298310224127140
34312415836190215
45716621448254290
57220727060317365
68624832672380440
710029038284444515
811533143896507590
9129373494108570665
10143414550121634740

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%23.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%23.00.00.0100.0%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%23.00.00.0100.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%23.00.00.0100.0%

Fundamentals of Jiangsu Hengrui Medicine Co Ltd

About Jiangsu Hengrui Medicine Co Ltd

Jiangsu Hengrui Medicine Co., Ltd., a pharmaceutical company, develops, manufactures, and commercializes drugs worldwide. The company is developing Camrelizumab, Pyrotinib, Fuzuloparib, Adebrelimab, Rezvilutamide, Famitinib, Dalpiciclib, SHR-1701, SHR-1501, SHR-A1811, SHR1459, Mecapegfilgrastim, Apatinib, Linperlisib, and SHR2554 for oncology indications; SHR4640, Retagliptin, SHR20004, SHR-1209, SHR3824, INS068, SHR7280, and SHR2285 for cardiovascular and metabolism indications. It is also developing SHR0302, Hetrombopag, Vunakizumab, and SHR-1703 for autoimmune indications; SHR0410, Imrecoxib, Remimazolam, and SHR8554 for pain; Oteseconazole and HRS9950 for anti-infection; and SHR8028, SHR8058, SHR-1707, and SHR-1222 for other indications. The company was founded in 1970 and is based in Lianyungang, China.

Fundamental data was last updated by Penke on 2024-04-17 06:29:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Jiangsu Hengrui Medicine Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Jiangsu Hengrui Medicine Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Jiangsu Hengrui Medicine Co Ltd to the Drug Manufacturers - General industry mean.
  • A Net Profit Margin of 18.4% means that ¥0.18 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Jiangsu Hengrui Medicine Co Ltd:

  • The MRQ is 18.4%. The company is making a huge profit. +2
  • The TTM is 18.4%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ18.4%TTM18.4%0.0%
TTM18.4%YOY17.5%+0.9%
TTM18.4%5Y21.0%-2.6%
5Y21.0%10Y21.5%-0.5%
1.1.2. Return on Assets

Shows how efficient Jiangsu Hengrui Medicine Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Jiangsu Hengrui Medicine Co Ltd to the Drug Manufacturers - General industry mean.
  • 9.2% Return on Assets means that Jiangsu Hengrui Medicine Co Ltd generated ¥0.09 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Jiangsu Hengrui Medicine Co Ltd:

  • The MRQ is 9.2%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 9.2%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ9.2%TTM9.2%0.0%
TTM9.2%YOY11.5%-2.3%
TTM9.2%5Y15.3%-6.1%
5Y15.3%10Y16.5%-1.2%
1.1.3. Return on Equity

Shows how efficient Jiangsu Hengrui Medicine Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Jiangsu Hengrui Medicine Co Ltd to the Drug Manufacturers - General industry mean.
  • 10.3% Return on Equity means Jiangsu Hengrui Medicine Co Ltd generated ¥0.10 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Jiangsu Hengrui Medicine Co Ltd:

  • The MRQ is 10.3%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 10.3%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ10.3%TTM10.3%0.0%
TTM10.3%YOY12.9%-2.6%
TTM10.3%5Y17.2%-6.9%
5Y17.2%10Y18.8%-1.6%

1.2. Operating Efficiency of Jiangsu Hengrui Medicine Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Jiangsu Hengrui Medicine Co Ltd is operating .

  • Measures how much profit Jiangsu Hengrui Medicine Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Jiangsu Hengrui Medicine Co Ltd to the Drug Manufacturers - General industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Jiangsu Hengrui Medicine Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY14.6%-14.6%
TTM-5Y16.8%-16.8%
5Y16.8%10Y16.5%+0.3%
1.2.2. Operating Ratio

Measures how efficient Jiangsu Hengrui Medicine Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - General industry mean).
  • An Operation Ratio of 1.01 means that the operating costs are ¥1.01 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Jiangsu Hengrui Medicine Co Ltd:

  • The MRQ is 1.007. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.007. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.007TTM1.0070.000
TTM1.007YOY0.987+0.020
TTM1.0075Y0.930+0.076
5Y0.93010Y0.758+0.172

1.3. Liquidity of Jiangsu Hengrui Medicine Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Jiangsu Hengrui Medicine Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - General industry mean).
  • A Current Ratio of 8.50 means the company has ¥8.50 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Jiangsu Hengrui Medicine Co Ltd:

  • The MRQ is 8.500. The company is very able to pay all its short-term debts. +2
  • The TTM is 8.500. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ8.500TTM8.5000.000
TTM8.500YOY8.875-0.375
TTM8.5005Y8.216+0.284
5Y8.21610Y6.539+1.677
1.3.2. Quick Ratio

Measures if Jiangsu Hengrui Medicine Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Jiangsu Hengrui Medicine Co Ltd to the Drug Manufacturers - General industry mean.
  • A Quick Ratio of 2.38 means the company can pay off ¥2.38 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Jiangsu Hengrui Medicine Co Ltd:

  • The MRQ is 2.377. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.377. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.377TTM2.3770.000
TTM2.377YOY2.858-0.481
TTM2.3775Y3.826-1.449
5Y3.82610Y3.960-0.134

1.4. Solvency of Jiangsu Hengrui Medicine Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Jiangsu Hengrui Medicine Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Jiangsu Hengrui Medicine Co Ltd to Drug Manufacturers - General industry mean.
  • A Debt to Asset Ratio of 0.09 means that Jiangsu Hengrui Medicine Co Ltd assets are financed with 9.3% credit (debt) and the remaining percentage (100% - 9.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Jiangsu Hengrui Medicine Co Ltd:

  • The MRQ is 0.093. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.093. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.093TTM0.0930.000
TTM0.093YOY0.094-0.001
TTM0.0935Y0.102-0.009
5Y0.10210Y0.099+0.003
1.4.2. Debt to Equity Ratio

Measures if Jiangsu Hengrui Medicine Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Jiangsu Hengrui Medicine Co Ltd to the Drug Manufacturers - General industry mean.
  • A Debt to Equity ratio of 10.4% means that company has ¥0.10 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Jiangsu Hengrui Medicine Co Ltd:

  • The MRQ is 0.104. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.104. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.104TTM0.1040.000
TTM0.104YOY0.106-0.001
TTM0.1045Y0.115-0.011
5Y0.11510Y0.113+0.002

2. Market Valuation of Jiangsu Hengrui Medicine Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Jiangsu Hengrui Medicine Co Ltd generates.

  • Above 15 is considered overpriced but always compare Jiangsu Hengrui Medicine Co Ltd to the Drug Manufacturers - General industry mean.
  • A PE ratio of 62.92 means the investor is paying ¥62.92 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Jiangsu Hengrui Medicine Co Ltd:

  • The EOD is 72.342. Based on the earnings, the company is expensive. -2
  • The MRQ is 62.920. Based on the earnings, the company is expensive. -2
  • The TTM is 62.920. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD72.342MRQ62.920+9.422
MRQ62.920TTM62.9200.000
TTM62.920YOY71.595-8.676
TTM62.9205Y86.950-24.031
5Y86.95010Y118.138-31.188
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Jiangsu Hengrui Medicine Co Ltd:

  • The EOD is -388.753. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -338.119. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -338.119. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-388.753MRQ-338.119-50.634
MRQ-338.119TTM-338.1190.000
TTM-338.119YOY126.985-465.103
TTM-338.1195Y71.611-409.730
5Y71.61110Y137.654-66.043
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Jiangsu Hengrui Medicine Co Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - General industry mean).
  • A PB ratio of 6.40 means the investor is paying ¥6.40 for each ¥1 in book value.

Let's take a look of the Price to Book Ratio trends of Jiangsu Hengrui Medicine Co Ltd:

  • The EOD is 7.357. Based on the equity, the company is overpriced. -1
  • The MRQ is 6.398. Based on the equity, the company is overpriced. -1
  • The TTM is 6.398. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD7.357MRQ6.398+0.958
MRQ6.398TTM6.3980.000
TTM6.398YOY9.118-2.720
TTM6.3985Y15.613-9.214
5Y15.61310Y22.370-6.757
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Jiangsu Hengrui Medicine Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.4600.4600%0.750-39%0.704-35%0.517-11%
Book Value Per Share--6.0226.0220%5.562+8%4.682+29%3.189+89%
Current Ratio--8.5008.5000%8.875-4%8.216+3%6.539+30%
Debt To Asset Ratio--0.0930.0930%0.094-1%0.102-9%0.099-6%
Debt To Equity Ratio--0.1040.1040%0.106-1%0.115-9%0.113-8%
Dividend Per Share--0.1590.1590%0.167-5%0.134+19%0.081+97%
Eps--0.6120.6120%0.708-14%0.756-19%0.546+12%
Free Cash Flow Per Share---0.114-0.1140%0.399-129%0.319-136%0.281-141%
Free Cash Flow To Equity Per Share---0.114-0.1140%0.243-147%0.263-143%0.251-145%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--1.869--------
Intrinsic Value_10Y_min---5.888--------
Intrinsic Value_1Y_max--0.292--------
Intrinsic Value_1Y_min--0.035--------
Intrinsic Value_3Y_max--0.797--------
Intrinsic Value_3Y_min---0.436--------
Intrinsic Value_5Y_max--1.206--------
Intrinsic Value_5Y_min---1.496--------
Market Cap282589691494.400+13%245782957617.220245782957617.2200%324341764158.940-24%435607096077.968-44%370300427769.017-34%
Net Profit Margin--0.1840.1840%0.175+5%0.210-12%0.215-15%
Operating Margin----0%0.146-100%0.168-100%0.165-100%
Operating Ratio--1.0071.0070%0.987+2%0.930+8%0.758+33%
Pb Ratio7.357+13%6.3986.3980%9.118-30%15.613-59%22.370-71%
Pe Ratio72.342+13%62.92062.9200%71.595-12%86.950-28%118.138-47%
Price Per Share44.300+13%38.53038.5300%50.710-24%68.194-43%58.003-34%
Price To Free Cash Flow Ratio-388.753-15%-338.119-338.1190%126.985-366%71.611-572%137.654-346%
Price To Total Gains Ratio71.515+13%62.20062.2000%55.340+12%79.208-21%109.500-43%
Quick Ratio--2.3772.3770%2.858-17%3.826-38%3.960-40%
Return On Assets--0.0920.0920%0.115-20%0.153-40%0.165-44%
Return On Equity--0.1030.1030%0.129-20%0.172-40%0.188-45%
Total Gains Per Share--0.6190.6190%0.916-32%0.838-26%0.598+4%
Usd Book Value--5301015547.7575301015547.7570%4908909493.970+8%4126399606.245+28%2810071259.775+89%
Usd Book Value Change Per Share--0.0640.0640%0.103-39%0.097-35%0.071-11%
Usd Book Value Per Share--0.8310.8310%0.767+8%0.646+29%0.440+89%
Usd Dividend Per Share--0.0220.0220%0.023-5%0.018+19%0.011+97%
Usd Eps--0.0850.0850%0.098-14%0.104-19%0.075+12%
Usd Free Cash Flow---100314004.934-100314004.9340%352476953.304-128%281670664.046-136%247362494.442-141%
Usd Free Cash Flow Per Share---0.016-0.0160%0.055-129%0.044-136%0.039-141%
Usd Free Cash Flow To Equity Per Share---0.016-0.0160%0.034-147%0.036-143%0.035-145%
Usd Market Cap38997377426.227+13%33918048151.17633918048151.1760%44759163453.934-24%60113779258.760-44%51101459032.124-34%
Usd Price Per Share6.113+13%5.3175.3170%6.998-24%9.411-43%8.004-34%
Usd Profit--539070005.928539070005.9280%625170021.965-14%666775770.145-19%481473637.732+12%
Usd Revenue--2935987354.0502935987354.0500%3574962639.860-18%3191163707.557-8%2256509885.861+30%
Usd Total Gains Per Share--0.0850.0850%0.126-32%0.116-26%0.082+4%
 EOD+5 -3MRQTTM+0 -0YOY+11 -245Y+12 -2310Y+18 -17

3.2. Fundamental Score

Let's check the fundamental score of Jiangsu Hengrui Medicine Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1572.342
Price to Book Ratio (EOD)Between0-17.357
Net Profit Margin (MRQ)Greater than00.184
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than12.377
Current Ratio (MRQ)Greater than18.500
Debt to Asset Ratio (MRQ)Less than10.093
Debt to Equity Ratio (MRQ)Less than10.104
Return on Equity (MRQ)Greater than0.150.103
Return on Assets (MRQ)Greater than0.050.092
Total6/10 (60.0%)

3.3. Technical Score

Let's check the technical score of Jiangsu Hengrui Medicine Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5050.632
Ma 20Greater thanMa 5044.561
Ma 50Greater thanMa 10044.095
Ma 100Greater thanMa 20043.573
OpenGreater thanClose43.700
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets42,355,009
Total Liabilities3,941,853
Total Stockholder Equity37,823,808
 As reported
Total Liabilities 3,941,853
Total Stockholder Equity+ 37,823,808
Total Assets = 42,355,009

Assets

Total Assets42,355,009
Total Current Assets30,934,054
Long-term Assets11,420,955
Total Current Assets
Cash And Cash Equivalents 15,110,681
Short-term Investments 2,760,494
Net Receivables 5,891,397
Inventory 2,450,575
Other Current Assets 653,864
Total Current Assets  (as reported)30,934,054
Total Current Assets  (calculated)26,867,011
+/- 4,067,043
Long-term Assets
Property Plant Equipment 6,675,738
Intangible Assets 2,200,929
Long-term Assets Other 442,550
Long-term Assets  (as reported)11,420,955
Long-term Assets  (calculated)9,319,217
+/- 2,101,738

Liabilities & Shareholders' Equity

Total Current Liabilities3,639,220
Long-term Liabilities302,633
Total Stockholder Equity37,823,808
Total Current Liabilities
Short Long Term Debt 1,260,943
Accounts payable 1,767,549
Other Current Liabilities 11,378
Total Current Liabilities  (as reported)3,639,220
Total Current Liabilities  (calculated)3,039,870
+/- 599,350
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt98,861
Long-term Liabilities  (as reported)302,633
Long-term Liabilities  (calculated)98,861
+/- 203,773
Total Stockholder Equity
Retained Earnings 25,520,455
Total Stockholder Equity (as reported)37,823,808
Total Stockholder Equity (calculated)25,520,455
+/- 12,303,353
Other
Capital Stock6,379,002
Common Stock Shares Outstanding 6,379,002
Net Invested Capital 39,084,752
Net Working Capital 27,294,835
Property Plant and Equipment Gross 10,517,295



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-31
> Total Assets 
986,273
1,119,024
1,204,576
1,450,687
1,255,382
1,285,214
1,457,972
2,013,689
2,254,364
2,998,870
3,895,635
4,818,023
5,892,509
7,220,266
9,086,861
11,496,700
14,330,059
18,039,385
22,361,230
27,556,475
34,729,590
39,266,222
42,355,009
42,355,00939,266,22234,729,59027,556,47522,361,23018,039,38514,330,05911,496,7009,086,8617,220,2665,892,5094,818,0233,895,6352,998,8702,254,3642,013,6891,457,9721,285,2141,255,3821,450,6871,204,5761,119,024986,273
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9,378,354
11,393,222
14,468,531
18,069,392
22,311,305
28,050,036
30,187,749
30,934,054
30,934,05430,187,74928,050,03622,311,30518,069,39214,468,53111,393,2229,378,354000000000000000
       Cash And Cash Equivalents 
359,860
148,478
118,886
128,485
363,474
431,431
565,555
572,490
385,182
707,245
995,050
949,390
1,329,465
2,169,139
3,449,009
5,133,120
4,912,155
4,267,087
3,889,711
5,043,646
10,804,668
13,630,820
15,110,681
15,110,68113,630,82010,804,6685,043,6463,889,7114,267,0874,912,1555,133,1203,449,0092,169,1391,329,465949,390995,050707,245385,182572,490565,555431,431363,474128,485118,886148,478359,860
       Short-term Investments 
123,749
122,494
72,494
72,594
0
0
10,968
270,883
80,037
0
0
0
0
0
0
0
1,530,162
4,550,190
7,063,000
8,519,802
5,628,004
5,090,351
2,760,494
2,760,4945,090,3515,628,0048,519,8027,063,0004,550,1901,530,162000000080,037270,88310,9680072,59472,494122,494123,749
       Net Receivables 
197,260
291,917
324,353
384,348
325,767
290,841
265,357
528,006
889,414
1,233,909
1,726,378
2,173,135
2,491,833
2,608,896
2,987,292
3,471,635
3,795,229
4,437,385
5,445,513
6,416,852
5,073,694
4,632,515
5,891,397
5,891,3974,632,5155,073,6946,416,8525,445,5134,437,3853,795,2293,471,6352,987,2922,608,8962,491,8332,173,1351,726,3781,233,909889,414528,006265,357290,841325,767384,348324,353291,917197,260
       Other Current Assets 
8,601
39,230
16,845
37,378
6,258
9,525
4,838
8,363
36,402
30,111
93,848
308,634
354,594
203,874
212,706
250,632
519,087
424,152
7,703,594
638,131
602,253
1,090,403
653,864
653,8641,090,403602,253638,1317,703,594424,152519,087250,632212,706203,874354,594308,63493,84830,11136,4028,3634,8389,5256,25837,37816,84539,2308,601
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,936,837
3,570,854
4,291,838
5,245,171
6,679,554
9,078,473
11,420,955
11,420,9559,078,4736,679,5545,245,1714,291,8383,570,8542,936,8370000000000000000
       Property Plant Equipment 
195,167
420,491
548,793
692,361
491,121
479,989
508,529
501,252
543,967
609,254
813,149
1,035,786
1,336,275
1,766,440
1,624,179
1,770,200
2,473,942
3,078,753
3,686,018
4,074,800
4,585,239
6,275,603
6,675,738
6,675,7386,275,6034,585,2394,074,8003,686,0183,078,7532,473,9421,770,2001,624,1791,766,4401,336,2751,035,786813,149609,254543,967501,252508,529479,989491,121692,361548,793420,491195,167
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
78,926
81,035
117,527
155,650
599,428
0
0
0
000599,428155,650117,52781,03578,926000000000000000
       Intangible Assets 
0
2,157
14,364
13,565
657
0
0
32
0
50,278
52,337
51,345
66,895
202,674
199,876
195,847
284,716
279,255
272,682
349,762
341,253
702,437
2,200,929
2,200,929702,437341,253349,762272,682279,255284,716195,847199,876202,67466,89551,34552,33750,2780320065713,56514,3642,1570
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,936,837
-11
4,291,838
539,428
0
648,994
442,550
442,550648,9940539,4284,291,838-112,936,8370000000000000000
> Total Liabilities 
313,705
361,034
394,602
547,338
257,329
177,104
201,074
380,508
229,914
333,852
420,802
439,471
450,011
564,396
796,983
1,138,935
1,455,667
2,096,170
2,563,491
2,618,948
3,942,588
3,694,414
3,941,853
3,941,8533,694,4143,942,5882,618,9482,563,4912,096,1701,455,6671,138,935796,983564,396450,011439,471420,802333,852229,914380,508201,074177,104257,329547,338394,602361,034313,705
   > Total Current Liabilities 
189,898
241,034
305,102
433,338
237,329
122,691
140,853
355,009
229,914
323,852
400,802
429,471
440,011
554,396
714,530
1,053,158
1,364,875
2,050,399
2,493,634
2,472,635
3,771,593
3,401,532
3,639,220
3,639,2203,401,5323,771,5932,472,6352,493,6342,050,3991,364,8751,053,158714,530554,396440,011429,471400,802323,852229,914355,009140,853122,691237,329433,338305,102241,034189,898
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10,030
0
0
0
0
0
0
0
000000010,030000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10,030
0
0
0
0
0
0
1,260,943
1,260,94300000010,030000000000000000
       Accounts payable 
43,591
40,267
52,587
67,761
66,139
57,767
46,256
125,788
131,967
138,565
196,511
199,622
219,807
289,971
373,285
409,893
755,038
392,759
1,402,075
1,289,247
1,151,164
1,920,217
1,767,549
1,767,5491,920,2171,151,1641,289,2471,402,075392,759755,038409,893373,285289,971219,807199,622196,511138,565131,967125,78846,25657,76766,13967,76152,58740,26743,591
       Other Current Liabilities 
84,427
68,867
85,515
99,506
92,190
64,924
94,597
169,221
97,947
185,287
204,291
219,849
220,204
254,425
341,245
542,524
377,110
1,300,441
1,025,933
998,095
2,489,888
1,315,658
11,378
11,3781,315,6582,489,888998,0951,025,9331,300,441377,110542,524341,245254,425220,204219,849204,291185,28797,947169,22194,59764,92492,19099,50685,51568,86784,427
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
90,792
45,771
69,857
146,313
170,995
292,881
302,633
302,633292,881170,995146,31369,85745,77190,7920000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-10,030
0
0
0
0
0
151,589
98,861
98,861151,58900000-10,030000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,630
5,776
65,481
155,091
197,632
569,376
0
0569,376197,632155,09165,4815,7764,6300000000000000000
> Total Stockholder Equity
670,433
743,062
792,100
886,660
983,774
1,094,981
1,245,513
1,615,703
1,994,375
2,607,735
3,387,376
4,224,177
5,214,102
6,357,231
7,934,392
9,931,365
12,387,954
15,367,821
19,728,178
24,775,325
30,504,303
35,002,961
37,823,808
37,823,80835,002,96130,504,30324,775,32519,728,17815,367,82112,387,9549,931,3657,934,3926,357,2315,214,1024,224,1773,387,3762,607,7351,994,3751,615,7031,245,5131,094,981983,774886,660792,100743,062670,433
   Common Stock
132,850
212,560
255,072
255,072
255,072
255,072
331,594
431,072
517,286
620,743
749,433
1,124,150
1,236,565
1,360,221
1,505,016
1,956,499
2,347,460
2,832,648
3,685,862
4,422,814
5,331,717
6,396,012
0
06,396,0125,331,7174,422,8143,685,8622,832,6482,347,4601,956,4991,505,0161,360,2211,236,5651,124,150749,433620,743517,286431,072331,594255,072255,072255,072255,072212,560132,850
   Retained Earnings 
64,945
85,011
74,537
149,900
224,411
247,058
433,041
662,377
909,890
1,352,705
1,822,330
2,334,547
3,110,248
4,019,251
5,924,062
7,644,134
9,646,145
12,076,394
15,207,230
19,102,848
23,529,646
25,927,859
25,520,455
25,520,45525,927,85923,529,64619,102,84815,207,23012,076,3949,646,1457,644,1345,924,0624,019,2513,110,2482,334,5471,822,3301,352,705909,890662,377433,041247,058224,411149,90074,53785,01164,945
   Capital Surplus 00000000000000000000000
   Treasury Stock00000-528,473-43,428-87,830000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-1,501
-408
334
-9,645
6,531
-4,793
-12,159
0
0-12,159-4,7936,531-9,645334-408-1,501000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue22,343,597
Cost of Revenue-3,475,445
Gross Profit18,868,15318,868,153
 
Operating Income (+$)
Gross Profit18,868,153
Operating Expense-18,563,249
Operating Income3,780,349304,904
 
Operating Expense (+$)
Research Development5,114,509
Selling General Administrative9,553,139
Selling And Marketing Expenses-
Operating Expense18,563,24914,667,648
 
Net Interest Income (+$)
Interest Income283,082
Interest Expense-9,179
Other Finance Cost-104,204
Net Interest Income378,106
 
Pretax Income (+$)
Operating Income3,780,349
Net Interest Income378,106
Other Non-Operating Income Expenses-
Income Before Tax (EBT)4,246,8763,780,349
EBIT - interestExpense = -9,179
4,206,694
4,215,873
Interest Expense9,179
Earnings Before Interest and Taxes (EBIT)-4,256,055
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax4,246,876
Tax Provision-76,822
Net Income From Continuing Ops4,170,0544,170,054
Net Income4,206,694
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net--378,106
 

Technical Analysis of Jiangsu Hengrui Medicine Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Jiangsu Hengrui Medicine Co Ltd. The general trend of Jiangsu Hengrui Medicine Co Ltd is BULLISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Jiangsu Hengrui Medicine Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (28.6%) Bearish trend (-28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Jiangsu Hengrui Medicine Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 45.50 < 46.86 < 48.53.

The bearish price targets are: 41.60 > 36.01 > 35.51.

Tweet this
Jiangsu Hengrui Medicine Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Jiangsu Hengrui Medicine Co Ltd. The current mas is .

The long score for the Moving Averages is 9/14.
The longshort score for the Moving Averages is 4/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Jiangsu Hengrui Medicine Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Jiangsu Hengrui Medicine Co Ltd. The current macd is -0.33315309.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Jiangsu Hengrui Medicine Co Ltd price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Jiangsu Hengrui Medicine Co Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Jiangsu Hengrui Medicine Co Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Jiangsu Hengrui Medicine Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartJiangsu Hengrui Medicine Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Jiangsu Hengrui Medicine Co Ltd. The current adx is 19.16.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Jiangsu Hengrui Medicine Co Ltd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Jiangsu Hengrui Medicine Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Jiangsu Hengrui Medicine Co Ltd. The current sar is 41.22.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Jiangsu Hengrui Medicine Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Jiangsu Hengrui Medicine Co Ltd. The current rsi is 50.63. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Jiangsu Hengrui Medicine Co Ltd Daily Relative Strength Index (RSI) ChartJiangsu Hengrui Medicine Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Jiangsu Hengrui Medicine Co Ltd. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Jiangsu Hengrui Medicine Co Ltd price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Jiangsu Hengrui Medicine Co Ltd Daily Stochastic Oscillator ChartJiangsu Hengrui Medicine Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Jiangsu Hengrui Medicine Co Ltd. The current cci is -22.84165699.

Jiangsu Hengrui Medicine Co Ltd Daily Commodity Channel Index (CCI) ChartJiangsu Hengrui Medicine Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Jiangsu Hengrui Medicine Co Ltd. The current cmo is 4.27185317.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Jiangsu Hengrui Medicine Co Ltd Daily Chande Momentum Oscillator (CMO) ChartJiangsu Hengrui Medicine Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Jiangsu Hengrui Medicine Co Ltd. The current willr is -35.29411765.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Jiangsu Hengrui Medicine Co Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Jiangsu Hengrui Medicine Co Ltd Daily Williams %R ChartJiangsu Hengrui Medicine Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Jiangsu Hengrui Medicine Co Ltd.

Jiangsu Hengrui Medicine Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Jiangsu Hengrui Medicine Co Ltd. The current atr is 1.30689731.

Jiangsu Hengrui Medicine Co Ltd Daily Average True Range (ATR) ChartJiangsu Hengrui Medicine Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Jiangsu Hengrui Medicine Co Ltd. The current obv is 939,694,914.

Jiangsu Hengrui Medicine Co Ltd Daily On-Balance Volume (OBV) ChartJiangsu Hengrui Medicine Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Jiangsu Hengrui Medicine Co Ltd. The current mfi is 53.41.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Jiangsu Hengrui Medicine Co Ltd Daily Money Flow Index (MFI) ChartJiangsu Hengrui Medicine Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Jiangsu Hengrui Medicine Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-28STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-30SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-04CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-05BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-08STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-11CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-14STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-18STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-19STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-25STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-26STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-02STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-05WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-10RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-15RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-18RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-23WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-24SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-30BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-31ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-02-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-22CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-05CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-07SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-08WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-02CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-03SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-11STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-17DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-04-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside

6.3. Candlestick Patterns

Jiangsu Hengrui Medicine Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Jiangsu Hengrui Medicine Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5050.632
Ma 20Greater thanMa 5044.561
Ma 50Greater thanMa 10044.095
Ma 100Greater thanMa 20043.573
OpenGreater thanClose43.700
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Jiangsu Hengrui Medicine Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Jiangsu Hengrui Medicine Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Jiangsu Hengrui Medicine Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Jiangsu Hengrui Medicine Co Ltd

I send you an email if I find something interesting about Jiangsu Hengrui Medicine Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Jiangsu Hengrui Medicine Co Ltd.

Receive notifications about Jiangsu Hengrui Medicine Co Ltd in your mailbox!